5Shautad M, Kimis V, Toni L, et al. Ripley etoricoxib : a highly se- lective COX-2 inhibitor. Ann Pharmacother, 2005,39 ( 6 ) : 854- 862.
6张胜利,黄烽.脊柱关节炎的发展历史.北京:人民卫生出版社,2011:1-7.
7Kawamura M, Ohara H, Go K, et al. Neurotropin induces antinoci- ceptive effect by enhancing descending pain inhibitory systems in- volving5-HT3 and noradrenergic alpha2 receptors in spinal dorsal horn. Life Sci, 1998,62( 11 ) :2181-2190.
8Gossec L, Dvander H, Melian A. Efficacy of cyclooxygenase-2 in- hibition by etoricoxib and naproxen on the axial m an ifestations of ankylosing spondylitis in the presence of peripheral arthritis. Ann Rheum Dis,2005,64(7) :1563-1567.
9Bernard C, Garys W, James M. Card iovascular safety and gastro- intestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial ( The MEDAL study ). Rheumatology, 2009,10(8) :1093.
10Legrand E, Hoppa E, Bouvard B, et al. Disc herniation-in- duced sciatica: medical or surgical treatment? Rev Prat, 2008. 58(3) .. 285-293.
